Clinical Trials Directory

Trials / Completed

CompletedNCT01484106

Cardiac Output Monitoring Managing Intravenous Therapy (COMMIT) to Treat Emergency Department Severe Sepsis

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
65 (actual)
Sponsor
Cheetah Medical Inc. · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The primary objective of this study is to test whether a fluid resuscitation protocol guided by non-invasive hemodynamic measures reduces the progression of organ dysfunction (defined by an increase in the Serial Organ Failure Assessment Score ≥ 1 over the first 72 hours) in sepsis patients presenting to the Emergency Department without evidence of shock.

Conditions

Interventions

TypeNameDescription
OTHERFluid ResuscitationIn the Treatment group, this information will be used in a specific 4-hour treatment algorithm to guide fluid administration that is summarized in Figure 1. The information provided by the NICOM in response to the fluid bolus will be used to assess whether the subject is "fluid responsive" (FR).
OTHERStandard of CareStandard of Care

Timeline

Start date
2011-11-01
Primary completion
2014-08-01
Completion
2014-08-01
First posted
2011-12-02
Last updated
2021-07-21

Locations

12 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT01484106. Inclusion in this directory is not an endorsement.

Cardiac Output Monitoring Managing Intravenous Therapy (COMMIT) to Treat Emergency Department Severe Sepsis (NCT01484106) · Clinical Trials Directory